| تعداد نشریات | 20 |
| تعداد شمارهها | 1,230 |
| تعداد مقالات | 11,205 |
| تعداد مشاهده مقاله | 78,037,592 |
| تعداد دریافت فایل اصل مقاله | 103,635,186 |
Hypothyroidism in β-Thalassemia Intermedia Patients with and without Hydroxyurea | ||
| Iranian Journal of Medical Sciences | ||
| مقاله 8، دوره 39، شماره 1، فروردین 2014، صفحه 60-63 اصل مقاله (210.94 K) | ||
| نوع مقاله: Brief Report(s) | ||
| نویسندگان | ||
| Omid Reza Zekavat* 1؛ Ali Reza Makarem2؛ Sezaneh Haghpanah1؛ Zohreh Karamizadeh3؛ Parvin Javad1؛ Mehran Karimi1 | ||
| 1Hematology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran | ||
| 2Student Research Committee, Jahrom University of Medical Sciences, Jahrom, Iran | ||
| 3Department of Pediatric Endocrinology, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran | ||
| چکیده | ||
| Hydroxyurea (HU) has been successfully used in patients with β-thalassemia intermedia (β-TI). We aimed to evaluate the effect of the long-term use of HU on thyroid function in patients with β-TI. Seventy-five patients with β-TI aged≥11 years and taking HU were randomly selected during 2010 in southern Iran. Thirty-one patients with β-TI without HU were considered as a control group. Serum levels of thyroid stimulating hormone (TSH) and T4 were measured. The mean age of the participants was 22.7±5.1 years (age range=12-41 years). Serum ferritin level had no significant correlation with HU consumption (P>0.05). Overall, we detected 10 (9.4%) patients with hypothyroidism. We found that the use of HU at a dose of 8-15 mg/kg/day has no significant association with thyroid function in β-TI patients. However, due to the small sample size in our study, documentation of this finding needs further studies with higher numbers of patients. | ||
| کلیدواژهها | ||
| Thalassemia intermedia؛ Hydroxyurea؛ Thyroid function | ||
|
آمار تعداد مشاهده مقاله: 4,092 تعداد دریافت فایل اصل مقاله: 1,737 |
||